HEADER TRANSFERASE 10-MAY-00 1EZF TITLE CRYSTAL STRUCTURE OF HUMAN SQUALENE SYNTHASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 31-370; COMPND 5 SYNONYM: SQUALENE SYNTHETASE; COMPND 6 EC: 2.5.1.21; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PHSS9 KEYWDS ISOPRENOID SYNTHASE FOLD, ALL ALPHA-HELIX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.PANDIT,D.E.DANLEY,G.K.SCHULTE,S.M.MAZZALUPO,T.A.PAULY,C.M.HAYWARD, AUTHOR 2 E.S.HAMANAKA,J.F.THOMPSON,H.J.HARWOOD REVDAT 4 31-JAN-18 1EZF 1 REMARK REVDAT 3 24-FEB-09 1EZF 1 VERSN REVDAT 2 01-APR-03 1EZF 1 JRNL REVDAT 1 18-OCT-00 1EZF 0 JRNL AUTH J.PANDIT,D.E.DANLEY,G.K.SCHULTE,S.MAZZALUPO,T.A.PAULY, JRNL AUTH 2 C.M.HAYWARD,E.S.HAMANAKA,J.F.THOMPSON,H.J.HARWOOD JR. JRNL TITL CRYSTAL STRUCTURE OF HUMAN SQUALENE SYNTHASE. A KEY ENZYME JRNL TITL 2 IN CHOLESTEROL BIOSYNTHESIS. JRNL REF J.BIOL.CHEM. V. 275 30610 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10896663 JRNL DOI 10.1074/JBC.M004132200 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 54783 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE-R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM "SHELL" METHOD. REF: REMARK 3 GJ KLEYWEGT & TA JONES, REMARK 3 STRUCTURE 3, 535-540 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3340 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4359 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE : 0.3090 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.07 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 332 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7834 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 BOND ANGLES (DEGREES) : 1.590 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1EZF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-00. REMARK 100 THE DEPOSITION ID IS D_1000011056. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-95 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 35.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.14100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIRAS REMARK 200 SOFTWARE USED: MLPHARE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25-30% PEG 4000, 0.1M SODIUM CITRATE, REMARK 280 PH5.6, 0.2M AMMONIUM ACETATE , VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 20K, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.38000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.08500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.96000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.08500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.38000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.96000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 31 REMARK 465 ASP A 32 REMARK 465 ARG A 33 REMARK 465 ASN A 34 REMARK 465 SER A 35 REMARK 465 LEU A 36 REMARK 465 SER A 37 REMARK 465 ARG A 317 REMARK 465 LYS A 318 REMARK 465 GLY A 319 REMARK 465 GLN A 320 REMARK 465 ALA A 321 REMARK 465 VAL A 322 REMARK 465 THR A 323 REMARK 465 LEU A 324 REMARK 465 MET A 325 REMARK 465 MET A 326 REMARK 465 MET B 31 REMARK 465 ASP B 32 REMARK 465 ARG B 33 REMARK 465 LYS B 315 REMARK 465 ILE B 316 REMARK 465 ARG B 317 REMARK 465 LYS B 318 REMARK 465 GLY B 319 REMARK 465 GLN B 320 REMARK 465 ALA B 321 REMARK 465 VAL B 322 REMARK 465 THR B 323 REMARK 465 LEU B 324 REMARK 465 MET B 325 REMARK 465 MET B 326 REMARK 465 ASP B 327 REMARK 465 MET C 31 REMARK 465 ASP C 32 REMARK 465 ARG C 33 REMARK 465 ASN C 34 REMARK 465 SER C 35 REMARK 465 LEU C 36 REMARK 465 SER C 37 REMARK 465 LYS C 315 REMARK 465 ILE C 316 REMARK 465 ARG C 317 REMARK 465 LYS C 318 REMARK 465 GLY C 319 REMARK 465 GLN C 320 REMARK 465 ALA C 321 REMARK 465 VAL C 322 REMARK 465 THR C 323 REMARK 465 LEU C 324 REMARK 465 MET C 325 REMARK 465 MET C 326 REMARK 465 ASP C 327 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL B 314 CG1 CG2 REMARK 470 VAL C 314 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 115 35.50 -96.56 REMARK 500 ASP A 118 49.68 -95.96 REMARK 500 THR A 163 -82.46 -91.36 REMARK 500 ALA A 176 -37.12 -137.13 REMARK 500 GLU A 191 6.40 80.36 REMARK 500 ALA A 328 43.66 -72.71 REMARK 500 GLN A 369 -97.23 -99.95 REMARK 500 SER B 53 -20.50 -148.21 REMARK 500 ASP B 85 95.83 -59.80 REMARK 500 THR B 163 -76.72 -109.90 REMARK 500 ALA B 176 -34.67 -139.60 REMARK 500 GLU B 234 -4.46 -57.92 REMARK 500 VAL B 235 -67.91 -107.08 REMARK 500 TYR B 239 -38.80 -131.67 REMARK 500 LYS B 311 -56.99 -127.96 REMARK 500 GLN B 369 -103.80 -59.41 REMARK 500 SER C 53 -13.35 -147.90 REMARK 500 VAL C 162 103.85 62.53 REMARK 500 THR C 163 -70.17 -100.74 REMARK 500 ALA C 176 -41.34 -132.30 REMARK 500 GLN C 369 -86.65 -62.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IN0 A 991 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IN0 B 992 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IN0 C 995 DBREF 1EZF A 31 370 UNP P37268 FDFT_HUMAN 31 370 DBREF 1EZF B 31 370 UNP P37268 FDFT_HUMAN 31 370 DBREF 1EZF C 31 370 UNP P37268 FDFT_HUMAN 31 370 SEQADV 1EZF ARG A 33 UNP P37268 GLN 33 ENGINEERED SEQADV 1EZF ASN A 34 UNP P37268 ASP 34 ENGINEERED SEQADV 1EZF ASN A 38 UNP P37268 SER 38 ENGINEERED SEQADV 1EZF ARG B 33 UNP P37268 GLN 33 ENGINEERED SEQADV 1EZF ASN B 34 UNP P37268 ASP 34 ENGINEERED SEQADV 1EZF ASN B 38 UNP P37268 SER 38 ENGINEERED SEQADV 1EZF ARG C 33 UNP P37268 GLN 33 ENGINEERED SEQADV 1EZF ASN C 34 UNP P37268 ASP 34 ENGINEERED SEQADV 1EZF ASN C 38 UNP P37268 SER 38 ENGINEERED SEQRES 1 A 340 MET ASP ARG ASN SER LEU SER ASN SER LEU LYS THR CYS SEQRES 2 A 340 TYR LYS TYR LEU ASN GLN THR SER ARG SER PHE ALA ALA SEQRES 3 A 340 VAL ILE GLN ALA LEU ASP GLY GLU MET ARG ASN ALA VAL SEQRES 4 A 340 CYS ILE PHE TYR LEU VAL LEU ARG ALA LEU ASP THR LEU SEQRES 5 A 340 GLU ASP ASP MET THR ILE SER VAL GLU LYS LYS VAL PRO SEQRES 6 A 340 LEU LEU HIS ASN PHE HIS SER PHE LEU TYR GLN PRO ASP SEQRES 7 A 340 TRP ARG PHE MET GLU SER LYS GLU LYS ASP ARG GLN VAL SEQRES 8 A 340 LEU GLU ASP PHE PRO THR ILE SER LEU GLU PHE ARG ASN SEQRES 9 A 340 LEU ALA GLU LYS TYR GLN THR VAL ILE ALA ASP ILE CYS SEQRES 10 A 340 ARG ARG MET GLY ILE GLY MET ALA GLU PHE LEU ASP LYS SEQRES 11 A 340 HIS VAL THR SER GLU GLN GLU TRP ASP LYS TYR CYS HIS SEQRES 12 A 340 TYR VAL ALA GLY LEU VAL GLY ILE GLY LEU SER ARG LEU SEQRES 13 A 340 PHE SER ALA SER GLU PHE GLU ASP PRO LEU VAL GLY GLU SEQRES 14 A 340 ASP THR GLU ARG ALA ASN SER MET GLY LEU PHE LEU GLN SEQRES 15 A 340 LYS THR ASN ILE ILE ARG ASP TYR LEU GLU ASP GLN GLN SEQRES 16 A 340 GLY GLY ARG GLU PHE TRP PRO GLN GLU VAL TRP SER ARG SEQRES 17 A 340 TYR VAL LYS LYS LEU GLY ASP PHE ALA LYS PRO GLU ASN SEQRES 18 A 340 ILE ASP LEU ALA VAL GLN CYS LEU ASN GLU LEU ILE THR SEQRES 19 A 340 ASN ALA LEU HIS HIS ILE PRO ASP VAL ILE THR TYR LEU SEQRES 20 A 340 SER ARG LEU ARG ASN GLN SER VAL PHE ASN PHE CYS ALA SEQRES 21 A 340 ILE PRO GLN VAL MET ALA ILE ALA THR LEU ALA ALA CYS SEQRES 22 A 340 TYR ASN ASN GLN GLN VAL PHE LYS GLY ALA VAL LYS ILE SEQRES 23 A 340 ARG LYS GLY GLN ALA VAL THR LEU MET MET ASP ALA THR SEQRES 24 A 340 ASN MET PRO ALA VAL LYS ALA ILE ILE TYR GLN TYR MET SEQRES 25 A 340 GLU GLU ILE TYR HIS ARG ILE PRO ASP SER ASP PRO SER SEQRES 26 A 340 SER SER LYS THR ARG GLN ILE ILE SER THR ILE ARG THR SEQRES 27 A 340 GLN ASN SEQRES 1 B 340 MET ASP ARG ASN SER LEU SER ASN SER LEU LYS THR CYS SEQRES 2 B 340 TYR LYS TYR LEU ASN GLN THR SER ARG SER PHE ALA ALA SEQRES 3 B 340 VAL ILE GLN ALA LEU ASP GLY GLU MET ARG ASN ALA VAL SEQRES 4 B 340 CYS ILE PHE TYR LEU VAL LEU ARG ALA LEU ASP THR LEU SEQRES 5 B 340 GLU ASP ASP MET THR ILE SER VAL GLU LYS LYS VAL PRO SEQRES 6 B 340 LEU LEU HIS ASN PHE HIS SER PHE LEU TYR GLN PRO ASP SEQRES 7 B 340 TRP ARG PHE MET GLU SER LYS GLU LYS ASP ARG GLN VAL SEQRES 8 B 340 LEU GLU ASP PHE PRO THR ILE SER LEU GLU PHE ARG ASN SEQRES 9 B 340 LEU ALA GLU LYS TYR GLN THR VAL ILE ALA ASP ILE CYS SEQRES 10 B 340 ARG ARG MET GLY ILE GLY MET ALA GLU PHE LEU ASP LYS SEQRES 11 B 340 HIS VAL THR SER GLU GLN GLU TRP ASP LYS TYR CYS HIS SEQRES 12 B 340 TYR VAL ALA GLY LEU VAL GLY ILE GLY LEU SER ARG LEU SEQRES 13 B 340 PHE SER ALA SER GLU PHE GLU ASP PRO LEU VAL GLY GLU SEQRES 14 B 340 ASP THR GLU ARG ALA ASN SER MET GLY LEU PHE LEU GLN SEQRES 15 B 340 LYS THR ASN ILE ILE ARG ASP TYR LEU GLU ASP GLN GLN SEQRES 16 B 340 GLY GLY ARG GLU PHE TRP PRO GLN GLU VAL TRP SER ARG SEQRES 17 B 340 TYR VAL LYS LYS LEU GLY ASP PHE ALA LYS PRO GLU ASN SEQRES 18 B 340 ILE ASP LEU ALA VAL GLN CYS LEU ASN GLU LEU ILE THR SEQRES 19 B 340 ASN ALA LEU HIS HIS ILE PRO ASP VAL ILE THR TYR LEU SEQRES 20 B 340 SER ARG LEU ARG ASN GLN SER VAL PHE ASN PHE CYS ALA SEQRES 21 B 340 ILE PRO GLN VAL MET ALA ILE ALA THR LEU ALA ALA CYS SEQRES 22 B 340 TYR ASN ASN GLN GLN VAL PHE LYS GLY ALA VAL LYS ILE SEQRES 23 B 340 ARG LYS GLY GLN ALA VAL THR LEU MET MET ASP ALA THR SEQRES 24 B 340 ASN MET PRO ALA VAL LYS ALA ILE ILE TYR GLN TYR MET SEQRES 25 B 340 GLU GLU ILE TYR HIS ARG ILE PRO ASP SER ASP PRO SER SEQRES 26 B 340 SER SER LYS THR ARG GLN ILE ILE SER THR ILE ARG THR SEQRES 27 B 340 GLN ASN SEQRES 1 C 340 MET ASP ARG ASN SER LEU SER ASN SER LEU LYS THR CYS SEQRES 2 C 340 TYR LYS TYR LEU ASN GLN THR SER ARG SER PHE ALA ALA SEQRES 3 C 340 VAL ILE GLN ALA LEU ASP GLY GLU MET ARG ASN ALA VAL SEQRES 4 C 340 CYS ILE PHE TYR LEU VAL LEU ARG ALA LEU ASP THR LEU SEQRES 5 C 340 GLU ASP ASP MET THR ILE SER VAL GLU LYS LYS VAL PRO SEQRES 6 C 340 LEU LEU HIS ASN PHE HIS SER PHE LEU TYR GLN PRO ASP SEQRES 7 C 340 TRP ARG PHE MET GLU SER LYS GLU LYS ASP ARG GLN VAL SEQRES 8 C 340 LEU GLU ASP PHE PRO THR ILE SER LEU GLU PHE ARG ASN SEQRES 9 C 340 LEU ALA GLU LYS TYR GLN THR VAL ILE ALA ASP ILE CYS SEQRES 10 C 340 ARG ARG MET GLY ILE GLY MET ALA GLU PHE LEU ASP LYS SEQRES 11 C 340 HIS VAL THR SER GLU GLN GLU TRP ASP LYS TYR CYS HIS SEQRES 12 C 340 TYR VAL ALA GLY LEU VAL GLY ILE GLY LEU SER ARG LEU SEQRES 13 C 340 PHE SER ALA SER GLU PHE GLU ASP PRO LEU VAL GLY GLU SEQRES 14 C 340 ASP THR GLU ARG ALA ASN SER MET GLY LEU PHE LEU GLN SEQRES 15 C 340 LYS THR ASN ILE ILE ARG ASP TYR LEU GLU ASP GLN GLN SEQRES 16 C 340 GLY GLY ARG GLU PHE TRP PRO GLN GLU VAL TRP SER ARG SEQRES 17 C 340 TYR VAL LYS LYS LEU GLY ASP PHE ALA LYS PRO GLU ASN SEQRES 18 C 340 ILE ASP LEU ALA VAL GLN CYS LEU ASN GLU LEU ILE THR SEQRES 19 C 340 ASN ALA LEU HIS HIS ILE PRO ASP VAL ILE THR TYR LEU SEQRES 20 C 340 SER ARG LEU ARG ASN GLN SER VAL PHE ASN PHE CYS ALA SEQRES 21 C 340 ILE PRO GLN VAL MET ALA ILE ALA THR LEU ALA ALA CYS SEQRES 22 C 340 TYR ASN ASN GLN GLN VAL PHE LYS GLY ALA VAL LYS ILE SEQRES 23 C 340 ARG LYS GLY GLN ALA VAL THR LEU MET MET ASP ALA THR SEQRES 24 C 340 ASN MET PRO ALA VAL LYS ALA ILE ILE TYR GLN TYR MET SEQRES 25 C 340 GLU GLU ILE TYR HIS ARG ILE PRO ASP SER ASP PRO SER SEQRES 26 C 340 SER SER LYS THR ARG GLN ILE ILE SER THR ILE ARG THR SEQRES 27 C 340 GLN ASN HET IN0 A 991 40 HET IN0 B 992 40 HET IN0 C 995 40 HETNAM IN0 N-{2-[TRANS-7-CHLORO-1-(2,2-DIMETHYL-PROPYL) -5- HETNAM 2 IN0 NAPHTHALEN-1-YL-2-OXO-1,2,3,5-TETRAHYDRO-BENZO[E] [1, HETNAM 3 IN0 4]OXAZEPIN-3-YL]-ACETYL}-ASPARTIC ACID HETSYN IN0 CP-320473 FORMUL 4 IN0 3(C30 H31 CL N2 O7) FORMUL 7 HOH *410(H2 O) HELIX 1 1 ASN A 38 SER A 51 1 14 HELIX 2 2 SER A 53 ALA A 60 1 8 HELIX 3 3 GLU A 64 ASP A 85 1 22 HELIX 4 4 SER A 89 LEU A 104 1 16 HELIX 5 5 ASP A 118 ASP A 124 1 7 HELIX 6 6 ASP A 124 ASN A 134 1 11 HELIX 7 7 ALA A 136 ASP A 159 1 24 HELIX 8 8 SER A 164 ALA A 176 1 13 HELIX 9 9 ALA A 176 SER A 190 1 15 HELIX 10 10 ASP A 194 ASP A 200 1 7 HELIX 11 11 ASP A 200 ASP A 219 1 20 HELIX 12 12 ASP A 219 GLY A 227 1 9 HELIX 13 13 PRO A 232 SER A 237 1 6 HELIX 14 14 LYS A 242 LYS A 248 5 7 HELIX 15 15 LYS A 248 GLU A 250 5 3 HELIX 16 16 ASN A 251 HIS A 268 1 18 HELIX 17 17 HIS A 269 ARG A 279 1 11 HELIX 18 18 ASN A 282 TYR A 304 1 23 HELIX 19 19 ASN A 306 LYS A 311 5 6 HELIX 20 20 ASN A 330 ILE A 349 1 20 HELIX 21 21 SER A 355 THR A 368 1 14 HELIX 22 22 SER B 37 THR B 50 1 14 HELIX 23 23 PHE B 54 GLN B 59 1 6 HELIX 24 24 ALA B 60 LEU B 61 5 2 HELIX 25 25 ASP B 62 GLY B 63 5 2 HELIX 26 26 GLU B 64 ASP B 85 1 22 HELIX 27 27 SER B 89 LEU B 104 1 16 HELIX 28 28 ASP B 118 ASP B 124 1 7 HELIX 29 29 ASP B 124 ASN B 134 1 11 HELIX 30 30 ALA B 136 LEU B 158 1 23 HELIX 31 31 SER B 164 ALA B 176 1 13 HELIX 32 32 ALA B 176 SER B 190 1 15 HELIX 33 33 ASP B 194 ASP B 200 1 7 HELIX 34 34 ASP B 200 ASP B 219 1 20 HELIX 35 35 ASP B 219 GLY B 226 1 8 HELIX 36 36 PRO B 232 SER B 237 1 6 HELIX 37 37 GLY B 244 LYS B 248 5 5 HELIX 38 38 LYS B 248 GLU B 250 5 3 HELIX 39 39 ASN B 251 HIS B 268 1 18 HELIX 40 40 HIS B 269 ARG B 279 1 11 HELIX 41 41 ASN B 282 TYR B 304 1 23 HELIX 42 42 ASN B 306 LYS B 311 5 6 HELIX 43 43 ASN B 330 ILE B 349 1 20 HELIX 44 44 SER B 355 GLN B 369 1 15 HELIX 45 45 ASN C 38 SER C 51 1 14 HELIX 46 46 PHE C 54 GLN C 59 1 6 HELIX 47 47 ALA C 60 LEU C 61 5 2 HELIX 48 48 ASP C 62 GLY C 63 5 2 HELIX 49 49 GLU C 64 ASP C 85 1 22 HELIX 50 50 SER C 89 LEU C 104 1 16 HELIX 51 51 ASP C 118 ASP C 124 1 7 HELIX 52 52 ASP C 124 ASN C 134 1 11 HELIX 53 53 ALA C 136 PHE C 157 1 22 HELIX 54 54 SER C 164 ALA C 176 1 13 HELIX 55 55 ALA C 176 SER C 190 1 15 HELIX 56 56 ASP C 194 ASP C 200 1 7 HELIX 57 57 ASP C 200 ASP C 219 1 20 HELIX 58 58 ASP C 219 GLY C 226 1 8 HELIX 59 59 PRO C 232 SER C 237 1 6 HELIX 60 60 LYS C 242 LYS C 248 5 7 HELIX 61 61 LYS C 248 GLU C 250 5 3 HELIX 62 62 ASN C 251 HIS C 268 1 18 HELIX 63 63 HIS C 269 LEU C 280 1 12 HELIX 64 64 ASN C 282 TYR C 304 1 23 HELIX 65 65 ASN C 306 LYS C 311 5 6 HELIX 66 66 ASN C 330 ILE C 349 1 20 HELIX 67 67 SER C 355 GLN C 369 1 15 SITE 1 AC1 13 ARG A 52 SER A 53 PHE A 54 TYR A 73 SITE 2 AC1 13 ALA A 176 GLY A 180 LEU A 183 GLY A 208 SITE 3 AC1 13 LEU A 211 GLN A 212 PHE A 288 PRO A 292 SITE 4 AC1 13 HOH A1075 SITE 1 AC2 12 SER B 51 ARG B 52 SER B 53 PHE B 54 SITE 2 AC2 12 TYR B 73 VAL B 179 GLY B 180 LEU B 183 SITE 3 AC2 12 GLY B 208 LEU B 211 GLN B 212 PHE B 288 SITE 1 AC3 13 ARG C 52 SER C 53 PHE C 54 TYR C 73 SITE 2 AC3 13 LEU C 76 GLY C 180 LEU C 183 MET C 207 SITE 3 AC3 13 GLY C 208 LEU C 211 GLN C 212 PHE C 288 SITE 4 AC3 13 HOH C1036 CRYST1 76.760 87.920 154.170 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013028 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011374 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006486 0.00000 MASTER 336 0 3 67 0 0 11 6 0 0 0 81 END